Press Releases

Email Alerts

Jun 19, 2017

Biostage Announces Positive Preclinical Data of Cellspan™ Esophageal Implant Presented at the International Society for Stem Cell Research 2017 Annual Meeting

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
Jun 14, 2017

Biostage to Present at the 2017 Marcum MicroCap Conference

- Presentation with live audio webcast Friday, June 16th at 10:00 AM EDT -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 23, 2017

Biostage to Present at the Cell and Gene Exchange 2017

- Presentation with live video webcast today, May 23rd at 11:15 AM ET -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 22, 2017

Biostage Announces Receipt of Nasdaq Listing Determination

- Company to request hearing -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 11, 2017

Biostage Reports 2017 First Quarter Financial Results and Provides Business Update

- First quarter marked by operational improvements, clinical readiness and greater scientific validation

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

Show per page